Key Aspects of the Novartis Compound Collection Enhancement Project for the Compilation of a Comprehensive Chemogenomics Drug Discovery Screening Collection

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|5|4|397-411

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.5, Iss.4, 2005-05, pp. : 397-411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemogenomics: Bridging a Drug Discovery Gap

By  

Current Medicinal Chemistry, Vol. 9, Iss. 23, 2002-12 ,pp. : 2077-2084

Bentham Science Publishers

Access to resources Recommend Favorite

Genomics Strategies for Antifungal Drug Discovery - From Gene Discovery to Compound Screening

By  

Current Pharmaceutical Design, Vol. 8, Iss. 13, 2002-06 ,pp. : 1137-1154

Bentham Science Publishers

Access to resources Recommend Favorite

Computational approaches in chemogenomics and chemical biology: current and future impact on drug discovery

By Bajorath Jürgen  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 12, 2008-12 ,pp. : 1371-1376

Informa Healthcare

Access to resources Recommend Favorite

Iconix Pharmaceuticals, Inc. – removing barriers to efficient drug discovery through chemogenomics

By Engelberg Alan  

Pharmacogenomics, Vol. 5, Iss. 6, 2004-09 ,pp. : 741-744

Future Medicine

Access to resources Recommend Favorite

Kinase Chemogenomics: Targeting the Human Kinome for Target Validation and Drug Discovery

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 235-253

Bentham Science Publishers

Access to resources Recommend Favorite